Latest Shree Pacetronix stock price

Shree Pacetronix P/E Ratio

SHREEPAC • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
28.09
High Valuation
High - Growth expectations or overvalued

Current Valuation Metrics

P/E Ratio 28.09
Current Price ₹154.00
EPS (TTM) ₹2.08
Exchange BSE

Valuation Signal

Signal Overvalued
Historical Avg 20.97
Historical Range 20.0 - 22.81
Percentile 100.0%

Sector Context

Sector Average 53.59
Sector Median 31.12
Sector Rank #11 of 131
Sector Percentile 8.4%

Earnings Breakdown (TTM)

TTM EPS ₹6.84
Sept 2025 ₹3.64
Mar 2025 ₹1.26

Key P/E Ratio Insights for Shree Pacetronix

  • Stock appears overvalued with PE of 28.09, suggesting caution for new investments
  • Current PE is 34.0% above historical average
  • Trading at discount to sector average PE of 53.59

View the SHREEPAC equity price for detailed stock performance.

P/E Ratio Historical Trend for Shree Pacetronix

Historical P/E ratio trend based on annual earnings data. Lower P/E ratios may indicate undervaluation, while higher ratios suggest growth expectations.

Historical P/E Ratio Data

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2023 20.09 10.79 ₹216.75 BSE Moderate
2022 22.81 4.46 ₹101.75 BSE Moderate
2020 20.0 0.6 ₹12.00 BSE Moderate

Sector P/E Ratio Comparison

Comparing Shree Pacetronix with other companies in Healthcare sector
Sector Average
53.59
Sector Median
31.12
Lowest P/E
1.5
Highest P/E
628.04
Companies
131
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Welcure Drugs & Pharmace… WELCURE 1.5 ₹51 Low
Ind Swift Laboratories INDSWFTLAB 3.18 ₹733 Low
Murae Organisor MURAE 3.86 ₹55 Low
Fermenta Biotech FERMENTA 9.01 ₹1,010 Low
Zenith Drugs ZENITHDRUG 9.06 ₹84 Low
Galaxy Medicare GML 9.5 ₹32 Low
Balaxi Pharmaceuticals BALAXI 10.06 ₹139 Low
Natco Pharma NATCOPHARM 10.8 ₹17,006 Low
Vasundhara Rasayans VRL 11.3 ₹51 Low
Mohini Health & Hygiene MHHL 11.84 ₹69 Low